Zimmer, Tutogen give international extension to graft pact:
This article was originally published in Clinica
Zimmer Dental and biological implant specialist Tutogen Medical have extended a partnership to distribute the latter's Puros bone grafting products in Europe, the Middle East and Asia. Zimmer currently distributes the brand in the US, Canada and Latin America, and will be hoping to reinforce its position in a worldwide market that is valued at around $300m per year, according to Alachua, Florida-based Tutogen. The agreement relates to human- and animal-derived bone grafts used to enhance the mandible and maxilla. The grafts are manufactured using the patented Tutoplast process of removing unwanted fats, cells, antigens, and inactivates pathogens, while preserving valuable minerals and collagen matrix that lead to rapid bone regeneration.
You may also be interested in...
Operation Warp Speed will hold back initial shipments to ensure two-dose regimens can be completed; 15 December is ‘chalk’ target date for emergency authorization of Pfizer vaccine, OWS’ Gustave Perna says, calling it only a projection that does not impinge on FDA authority. Sending only half shipments also eases burden on cold shortage capacity at state and local level, he says.
CMS acknowledges stakeholders may need more details about the plan before it is finalized and a delay will give the agency more time to ‘consider the issue.’
Private Company Edition: Venture capital financings didn’t take a break during Thanksgiving week. In addition to the $800m Resilience raised to fund manufacturing services, SomaLogic closed a $121m series A round to fund its proteomic tools for drug discovery and diagnostics development.